Abstract
Accumulating evidence suggests that the pathophysiology or schizophrenia involves alterations in immune functions, both peripherally and centrally. Immunopsychiatric research has provided a number of candidate biomarkers that could aid estimating the risk of developing schizophrenia and/or predicting its clinical course or outcomes. This chapter summarizes the findings of immune dysfunctions along the clinical course of schizophrenia and discusses their potential value as predictive, trait or state biomarkers. Given the convergence of findings deriving from immunology, epidemiology, and genetics, the possibility of identifying immune-based biomarkers of schizophrenia seems realistic. Despite these promises, however, the field has realized that immune dysfunctions in schizophrenia may be as heterogeneous as the disorder itself. While challenging for psychiatric nosology, this heterogeneity offers the opportunity to define patient subgroups based on the presence or absence of distinct immune dysfunctions. This stratification may be clinically relevant for schizophrenic patients as it may help establishing personalized add-on therapies or preventive interventions with immunomodulating drugs.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abazyan B et al (2010) Prenatal interaction of mutant DISC1 and immune activation produces adult psychopathology. Biol Psychiatry 68:1172–1181. https://doi.org/10.1016/j.biopsych.2010.09.022
Ahmed A (2011) An overview of inflammation: mechanism and consequences. Front Biol 6:274–281
Al-Amin MM, Nasir Uddin MM, Mahmud Reza H (2013) Effects of antipsychotics on the inflammatory response system of patients with schizophrenia in peripheral blood mononuclear cell cultures. Clin Psychopharmacol Neurosci 11:144–151. https://doi.org/10.9758/cpn.2013.11.3.144
Al-Diwani AAJ, Pollak TA, Irani SR, Lennox BR (2017) Psychosis: an autoimmune disease? Immunology 152:388–401. https://doi.org/10.1111/imm.12795
Allswede DM, Buka SL, Yolken RH, Torrey EF, Cannon TD (2016) Elevated maternal cytokine levels at birth and risk for psychosis in adult offspring. Schizophr Res 172:41–45. https://doi.org/10.1016/j.schres.2016.02.022
Arakelyan A et al (2011) Functional characterization of the complement receptor type 1 and its circulating ligands in patients with schizophrenia. BMC Clin Pathol 11:10. https://doi.org/10.1186/1472-6890-11-10
Babulas V, Factor-Litvak P, Goetz R, Schaefer CA, Brown AS (2006) Prenatal exposure to maternal genital and reproductive infections and adult schizophrenia. Am J Psychiatry 163:927–929. https://doi.org/10.1176/ajp.2006.163.5.927
Balu DT (2016) The NMDA receptor and schizophrenia: from pathophysiology to treatment. Adv Pharmacol 76:351–382. https://doi.org/10.1016/bs.apha.2016.01.006
Benros ME, Pedersen MG, Rasmussen H, Eaton WW, Nordentoft M, Mortensen PB (2014) A nationwide study on the risk of autoimmune diseases in individuals with a personal or a family history of schizophrenia and related psychosis. Am J Psychiatry 171:218–226. https://doi.org/10.1176/appi.ajp.2013.13010086
Beutler B (2004) Innate immunity: an overview. Mol Immunol 40:845–859
Birnbaum R, Jaffe AE, Chen Q, Shin JH, Kleinman JE, Hyde TM, Weinberger DR (2017) Investigating the neuroimmunogenic architecture of schizophrenia. Mol Psychiatry. https://doi.org/10.1038/mp.2017.89
Boerrigter D et al (2017) Using blood cytokine measures to define high inflammatory biotype of schizophrenia and schizoaffective disorder. J Neuroinflammation 14:188. https://doi.org/10.1186/s12974-017-0962-y
Boyajyan A, Khoyetsyan A, Chavushyan A (2010) Alternative complement pathway in schizophrenia. Neurochem Res 35:894–898. https://doi.org/10.1007/s11064-010-0126-2
Brown AS (2011) The environment and susceptibility to schizophrenia. Prog Neurobiol 93:23–58. https://doi.org/10.1016/j.pneurobio.2010.09.003
Brown AS, Derkits EJ (2010) Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am J Psychiatry 167:261–280. https://doi.org/10.1176/appi.ajp.2009.09030361
Brown AS, Cohen P, Harkavy-Friedman J, Babulas V, Malaspina D, Gorman JM, Susser ES (2001) A.E. Bennett Research Award. Prenatal rubella, premorbid abnormalities, and adult schizophrenia. Biol Psychiatry 49:473–486
Brown AS et al (2004a) Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry 61:774–780. https://doi.org/10.1001/archpsyc.61.8.774
Brown AS et al (2004b) Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring. Am J Psychiatry 161:889–895. https://doi.org/10.1176/appi.ajp.161.5.889
Brown AS, Schaefer CA, Quesenberry CP Jr, Liu L, Babulas VP, Susser ES (2005) Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. Am J Psychiatry 162:767–773. https://doi.org/10.1176/appi.ajp.162.4.767
Brown AS et al (2009) Prenatal exposure to maternal infection and executive dysfunction in adult schizophrenia. Am J Psychiatry 166:683–690. https://doi.org/10.1176/appi.ajp.2008.08010089
Bruce LC, Peebles AMS (1903) Clinical and experimental observations on catatonia. J Ment Sci 49:614–628
Bruce LC, Peebles AMS (1904) Quantitative and qualitative leukocyte counts in various forms of mental disease. J Ment Sci 50:409–417
Buka SL, Tsuang MT, Torrey EF, Klebanoff MA, Bernstein D, Yolken RH (2001a) Maternal infections and subsequent psychosis among offspring. Arch Gen Psychiatry 58:1032–1037
Buka SL, Tsuang MT, Torrey EF, Klebanoff MA, Wagner RL, Yolken RH (2001b) Maternal cytokine levels during pregnancy and adult psychosis. Brain Behav Immun 15:411–420. https://doi.org/10.1006/brbi.2001.0644
Careaga M, Murai T, Bauman MD (2017) Maternal immune activation and autism spectrum disorder: from rodents to nonhuman and human primates. Biol Psychiatry 81:391–401. https://doi.org/10.1016/j.biopsych.2016.10.020
Chen ML, Tsai TC, Lin YY, Tsai YM, Wang LK, Lee MC, Tsai FM (2011) Antipsychotic drugs suppress the AKT/NF-kappaB pathway and regulate the differentiation of T-cell subsets. Immunol Lett 140:81–91. https://doi.org/10.1016/j.imlet.2011.06.011
Chen ML, Wu S, Tsai TC, Wang LK, Tsai FM (2013) Regulation of macrophage immune responses by antipsychotic drugs. Immunopharmacol Immunotoxicol 35:573–580. https://doi.org/10.3109/08923973.2013.828744
Choi GB et al (2016) The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring. Science (New York, NY) 351:933–939. https://doi.org/10.1126/science.aad0314
Clarke MC, Tanskanen A, Huttunen M, Whittaker JC, Cannon M (2009) Evidence for an interaction between familial liability and prenatal exposure to infection in the causation of schizophrenia. Am J Psychiatry 166:1025–1030. https://doi.org/10.1176/appi.ajp.2009.08010031
Consortium PG (2014) Biological insights from 108 schizophrenia-associated genetic loci. Nature 511:421–427. https://doi.org/10.1038/nature13595
Cotel MC et al (2015) Microglial activation in the rat brain following chronic antipsychotic treatment at clinically relevant doses. Eur Neuropsychopharmacol 25:2098–2107. https://doi.org/10.1016/j.euroneuro.2015.08.004
Debost JP, Larsen JT, Munk-Olsen T, Mortensen PB, Meyer U, Petersen L (2017) Joint effects of exposure to prenatal infection and peripubertal psychological trauma in schizophrenia. Schizophr Bull 43:171–179. https://doi.org/10.1093/schbul/sbw083
Dimitrov DH (2011) Correlation or coincidence between monocytosis and worsening of psychotic symptoms in veterans with schizophrenia? Schizophr Res 126:306–307. https://doi.org/10.1016/j.schres.2010.06.003
Drexhage RC et al (2010) Inflammatory gene expression in monocytes of patients with schizophrenia: overlap and difference with bipolar disorder. A study in naturalistically treated patients. Int J Neuropsychopharmacol 13:1369–1381. https://doi.org/10.1017/s1461145710000799
Du Clos TW (2000) Function of C-reactive protein. Ann Med 32:274–278
Eklund CM (2009) Proinflammatory cytokines in CRP baseline regulation. Adv Clin Chem 48:111–136
Esquirol JE (1845) Mental maladies, a treatise on insanity Philadelphia. Lea and Blanchard, Philadelphia, PA
Estes ML, McAllister AK (2015) Immune mediators in the brain and peripheral tissues in autism spectrum disorder. Nat Rev Neurosci 16:469–486. https://doi.org/10.1038/nrn3978
Estes ML, McAllister AK (2016) Maternal immune activation: implications for neuropsychiatric disorders. Science (New York, NY) 353:772–777. https://doi.org/10.1126/science.aag3194
Ezeoke A, Mellor A, Buckley P, Miller B (2013) A systematic, quantitative review of blood autoantibodies in schizophrenia. Schizophr Res 150:245–251. https://doi.org/10.1016/j.schres.2013.07.029
Fernandes BS et al (2016) C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications. Mol Psychiatry 21:554–564. https://doi.org/10.1038/mp.2015.87
Fillman SG et al (2013) Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia. Mol Psychiatry 18:206–214. https://doi.org/10.1038/mp.2012.110
Fillman SG, Weickert TW, Lenroot RK, Catts SV, Bruggemann JM, Catts VS, Weickert CS (2016) Elevated peripheral cytokines characterize a subgroup of people with schizophrenia displaying poor verbal fluency and reduced Broca’s area volume. Mol Psychiatry 21:1090–1098. https://doi.org/10.1038/mp.2015.90
Gao L, Li Z, Chang S, Wang J (2014) Association of interleukin-10 polymorphisms with schizophrenia: a meta-analysis. PLoS One 9:e90407. https://doi.org/10.1371/journal.pone.0090407
Gilmore JH, Jarskog LF (1997) Exposure to infection and brain development: cytokines in the pathogenesis of schizophrenia. Schizophr Res 24:365–367
Giovanoli S et al (2013) Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice. Science (New York, NY) 339:1095–1099. https://doi.org/10.1126/science.1228261
Goldsmith DR, Rapaport MH, Miller BJ (2016) A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry 21:1696–1709. https://doi.org/10.1038/mp.2016.3
Hamon, Paraire, Velluz (1952) Effect of R. P. 4560 on maniacal agitation. Ann Med Psychol (Paris) 110:331–335
Henriksen MG, Nordgaard J, Jansson LB (2017) Genetics of schizophrenia: overview of methods, findings and limitations. Front Hum Neurosci 11:322. https://doi.org/10.3389/fnhum.2017.00322
Holmes SE et al (2016) In vivo imaging of brain microglial activity in antipsychotic-free and medicated schizophrenia: a [11C](R)-PK11195 positron emission tomography study. Mol Psychiatry 21:1672–1679. https://doi.org/10.1038/mp.2016.180
Hudson ZD, Miller BJ (2016) Meta-analysis of cytokine and chemokine genes in schizophrenia. Clin Schizophr Relat Psychoses. https://doi.org/10.3371/csrp.humi.070516
Iwasaki A, Medzhitov R (2010) Regulation of adaptive immunity by the innate immune system. Science (New York, NY) 327:291–295. https://doi.org/10.1126/science.1183021
Iwasaki A, Medzhitov R (2015) Control of adaptive immunity by the innate immune system. Nat Immunol 16:343–353. https://doi.org/10.1038/ni.3123
Keller WR, Kum LM, Wehring HJ, Koola MM, Buchanan RW, Kelly DL (2013) A review of anti-inflammatory agents for symptoms of schizophrenia. J Psychopharmacol 27:337–342. https://doi.org/10.1177/0269881112467089
Khandaker GM, Pearson RM, Zammit S, Lewis G, Jones PB (2014) Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study. JAMA Psychiatry 71:1121–1128. https://doi.org/10.1001/jamapsychiatry.2014.1332
Khandaker GM, Cousins L, Deakin J, Lennox BR, Yolken R, Jones PB (2015) Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment. Lancet Psychiatry 2:258–270. https://doi.org/10.1016/s2215-0366(14)00122-9
Kirch DG (1993) Infection and autoimmunity as etiologic factors in schizophrenia: a review and reappraisal. Schizophr Bull 19:355–370
Kirkpatrick B, Miller BJ (2013) Inflammation and schizophrenia. Schizophr Bull 39:1174–1179. https://doi.org/10.1093/schbul/sbt141
Kowalski J, Blada P, Kucia K, Madej A, Herman ZS (2001) Neuroleptics normalize increased release of interleukin-1 beta and tumor necrosis factor-alpha from monocytes in schizophrenia. Schizophr Res 50:169–175
Kraepelin E (1890) Über Psychosen nach Influenza. Dtsch Med Wschr 16:209–212
Krause D et al (2012a) Monocytic HLA DR antigens in schizophrenic patients. Neurosci Res 72:87–93. https://doi.org/10.1016/j.neures.2011.09.004
Krause DL et al (2012b) Intracellular monocytic cytokine levels in schizophrenia show an alteration of IL-6. Eur Arch Psychiatry Clin Neurosci 262:393–401. https://doi.org/10.1007/s00406-012-0290-2
Kucharska-Mazur J et al (2014) Novel evidence for enhanced stem cell trafficking in antipsychotic-naive subjects during their first psychotic episode. J Psychiatr Res 49:18–24. https://doi.org/10.1016/j.jpsychires.2013.10.016
Laan W, Grobbee DE, Selten JP, Heijnen CJ, Kahn RS, Burger H (2010) Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: results from a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 71:520–527. https://doi.org/10.4088/JCP.09m05117yel
Labad J et al (2015) Stress biomarkers as predictors of transition to psychosis in at-risk mental states: roles for cortisol, prolactin and albumin. J Psychiatr Res 60:163–169. https://doi.org/10.1016/j.jpsychires.2014.10.011
Lehmann-Facius H (1937) Uber die Liquordiagnose der Schizophrenien. Klin Wochenschr 16:1646–1648
Mayilyan KR, Weinberger DR, Sim RB (2008) The complement system in schizophrenia. Drug News Perspect 21:200–210. https://doi.org/10.1358/dnp.2008.21.4.1213349
Mednick SA, Machon RA, Huttunen MO, Bonett D (1988) Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch Gen Psychiatry 45:189–192
Menninger KA (1919) Psychoses associated with influenza, I: general data: statistical analysis. JAMA 72:235–241
Menninger KA (1926) Influenza and schizophrenia: an analysis of post-influenzal “dementia praecox,” as of 1918, and five years later: further studies of the psychiatric aspects of influenza. Am J Psychiatry 5:469–529
Menninger KA (1928) The schizophrenia syndrome as a product of acute infectious disease. Arch Neurol Psychiatry 20:464–481
Meyer U (2014) Prenatal poly(i:C) exposure and other developmental immune activation models in rodent systems. Biol Psychiatry 75:307–315. https://doi.org/10.1016/j.biopsych.2013.07.011
Meyer U, Murray PJ, Urwyler A, Yee BK, Schedlowski M, Feldon J (2008) Adult behavioral and pharmacological dysfunctions following disruption of the fetal brain balance between pro-inflammatory and IL-10-mediated anti-inflammatory signaling. Mol Psychiatry 13:208–221. https://doi.org/10.1038/sj.mp.4002042
Meyer U, Feldon J, Yee BK (2009) A review of the fetal brain cytokine imbalance hypothesis of schizophrenia. Schizophr Bull 35:959–972. https://doi.org/10.1093/schbul/sbn022
Meyer U, Schwarz MJ, Muller N (2011) Inflammatory processes in schizophrenia: a promising neuroimmunological target for the treatment of negative/cognitive symptoms and beyond. Pharmacol Ther 132:96–110. https://doi.org/10.1016/j.pharmthera.2011.06.003
Miller BJ, Goldsmith DR (2017) Towards an immunophenotype of schizophrenia: progress, potential mechanisms, and future directions. Neuropsychopharmacology 42:299–317. https://doi.org/10.1038/npp.2016.211
Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B (2011) Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry 70:663–671. https://doi.org/10.1016/j.biopsych.2011.04.013
Miller BJ, Gassama B, Sebastian D, Buckley P, Mellor A (2013) Meta-analysis of lymphocytes in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry 73:993–999. https://doi.org/10.1016/j.biopsych.2012.09.007
Mogensen TH (2009) Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev 22:240–273. Table of Contents. https://doi.org/10.1128/cmr.00046-08
Mortensen PB, Norgaard-Pedersen B, Waltoft BL, Sorensen TL, Hougaard D, Yolken RH (2007) Early infections of Toxoplasma gondii and the later development of schizophrenia. Schizophr Bull 33:741–744. https://doi.org/10.1093/schbul/sbm009
Muller N et al (2002) Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia. Am J Psychiatry 159:1029–1034. https://doi.org/10.1176/appi.ajp.159.6.1029
Muller N et al (2004) COX-2 inhibition as a treatment approach in schizophrenia: immunological considerations and clinical effects of celecoxib add-on therapy. Eur Arch Psychiatry Clin Neurosci 254:14–22. https://doi.org/10.1007/s00406-004-0478-1
Muller N et al (2012) Impaired monocyte activation in schizophrenia. Psychiatry Res 198:341–346. https://doi.org/10.1016/j.psychres.2011.12.049
Nielsen PR, Benros ME, Mortensen PB (2014) Hospital contacts with infection and risk of schizophrenia: a population-based cohort study with linkage of Danish national registers. Schizophr Bull 40:1526–1532. https://doi.org/10.1093/schbul/sbt200
Nikkila HV, Muller K, Ahokas A, Miettinen K, Rimon R, Andersson LC (1999) Accumulation of macrophages in the CSF of schizophrenic patients during acute psychotic episodes. Am J Psychiatry 156:1725–1729. https://doi.org/10.1176/ajp.156.11.1725
Nikkila HV, Muller K, Ahokas A, Rimon R, Andersson LC (2001) Increased frequency of activated lymphocytes in the cerebrospinal fluid of patients with acute schizophrenia. Schizophr Res 49:99–105
Nitta M, Kishimoto T, Muller N, Weiser M, Davidson M, Kane JM, Correll CU (2013) Adjunctive use of nonsteroidal anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trials. Schizophr Bull 39:1230–1241. https://doi.org/10.1093/schbul/sbt070
Notter T, Meyer U (2017) Microglia and schizophrenia: where next? Mol Psychiatry 22:788–789. https://doi.org/10.1038/mp.2017.67
Notter T et al (2018a) Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia. Mol Psychiatry. https://doi.org/10.1038/mp.2016.248
Notter T, Coughlin JM, Sawa A, Meyer U (2018b) Reconceptualization of translocator protein as a biomarker of neuroinflammation in psychiatry. Mol Psychiatry 23(1):36–47
Parkin J, Cohen B (2001) An overview of the immune system. Lancet 357:1777–1789. https://doi.org/10.1016/s0140-6736(00)04904-7
Pearlman DM, Najjar S (2014) Meta-analysis of the association between N-methyl-d-aspartate receptor antibodies and schizophrenia, schizoaffective disorder, bipolar disorder, and major depressive disorder. Schizophr Res 157:249–258. https://doi.org/10.1016/j.schres.2014.05.001
Perkins DO et al (2015) Towards a psychosis risk blood diagnostic for persons experiencing high-risk symptoms: preliminary results from the NAPLS project. Schizophr Bull 41:419–428. https://doi.org/10.1093/schbul/sbu099
Presumey J, Bialas AR, Carroll MC (2017) Complement system in neural synapse elimination in development and disease. Adv Immunol 135:53–79. https://doi.org/10.1016/bs.ai.2017.06.004
Reemst K, Noctor SC, Lucassen PJ, Hol EM (2016) The indispensable roles of microglia and astrocytes during brain development. Front Hum Neurosci 10:566. https://doi.org/10.3389/fnhum.2016.00566
Rohleder N, Aringer M, Boentert M (2012) Role of interleukin-6 in stress, sleep, and fatigue. Ann N Y Acad Sci 1261:88–96. https://doi.org/10.1111/j.1749-6632.2012.06634.x
Santos Soria L, Moura Gubert C, Cereser KM, Gama CS, Kapczinski F (2012) Increased serum levels of C3 and C4 in patients with schizophrenia compared to eutymic patients with bipolar disorder and healthy. Rev Bras Psiquiatr 34:119–120
Sekar A et al (2016) Schizophrenia risk from complex variation of complement component 4. Nature 530:177–183. https://doi.org/10.1038/nature16549
Severance EG et al (2012) Complement C1q formation of immune complexes with milk caseins and wheat glutens in schizophrenia. Neurobiol Dis 48:447–453. https://doi.org/10.1016/j.nbd.2012.07.005
Shi J et al (2009) Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 460:753–757. https://doi.org/10.1038/nature08192
Shibuya M, Watanabe Y, Nunokawa A, Egawa J, Kaneko N, Igeta H, Someya T (2014) Interleukin 1 beta gene and risk of schizophrenia: detailed case-control and family-based studies and an updated meta-analysis. Hum Psychopharmacol 29:31–37. https://doi.org/10.1002/hup.2365
Smith SE, Li J, Garbett K, Mirnics K, Patterson PH (2007) Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci 27:10695–10702. https://doi.org/10.1523/jneurosci.2178-07.2007
Sommer IE, van Westrhenen R, Begemann MJ, de Witte LD, Leucht S, Kahn RS (2014) Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update. Schizophr Bull 40:181–191. https://doi.org/10.1093/schbul/sbt139
Sorensen HJ, Mortensen EL, Reinisch JM, Mednick SA (2009) Association between prenatal exposure to bacterial infection and risk of schizophrenia. Schizophr Bull 35:631–637. https://doi.org/10.1093/schbul/sbn121
Stojanovic A, Martorell L, Montalvo I, Ortega L, Monseny R, Vilella E, Labad J (2014) Increased serum interleukin-6 levels in early stages of psychosis: associations with at-risk mental states and the severity of psychotic symptoms. Psychoneuroendocrinology 41:23–32. https://doi.org/10.1016/j.psyneuen.2013.12.005
Sullivan PF, Kendler KS, Neale MC (2003) Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 60:1187–1192. https://doi.org/10.1001/archpsyc.60.12.1187
Suvisaari J, Haukka J, Tanskanen A, Hovi T, Lonnqvist J (1999) Association between prenatal exposure to poliovirus infection and adult schizophrenia. Am J Psychiatry 156:1100–1102. https://doi.org/10.1176/ajp.156.7.1100
Thion MS, Garel S (2017) On place and time: microglia in embryonic and perinatal brain development. Curr Opin Neurobiol 47:121–130. https://doi.org/10.1016/j.conb.2017.10.004
Torrey EF, Peterson MR (1973) Slow and latent viruses in schizophrenia. Lancet 2:22–24
Torrey EF, Rawlings R, Waldman IN (1988) Schizophrenic births and viral diseases in two states. Schizophr Res 1:73–77
Trepanier MO, Hopperton KE, Mizrahi R, Mechawar N, Bazinet RP (2016) Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review. Mol Psychiatry 21:1009–1026. https://doi.org/10.1038/mp.2016.90
Upthegrove R, Manzanares-Teson N, Barnes NM (2014) Cytokine function in medication-naive first episode psychosis: a systematic review and meta-analysis. Schizophr Res 155:101–108. https://doi.org/10.1016/j.schres.2014.03.005
van Kesteren CF et al (2017) Immune involvement in the pathogenesis of schizophrenia: a meta-analysis on postmortem brain studies. Transl Psychiatry 7:e1075. https://doi.org/10.1038/tp.2017.4
Wagner-Jauregg J (1887) Über die Einwirkung fieberhafter Erkrankungen auf Psychosen. Jahrbücher für Psychiatrie 7:94–131
Wagner-Jauregg J (1926) Fieberbehandlung bei Psychosen. Wien Med Wochenschr 76:79–82
Wang AK, Miller BJ (2017) Meta-analysis of cerebrospinal fluid cytokine and tryptophan catabolite alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder, and depression. Schizophr Bull. https://doi.org/10.1093/schbul/sbx035
Warrington R, Watson W, Kim HL, Antonetti FR (2011) An introduction to immunology and immunopathology. Allergy Asthma Clin Immunol 7(suppl 1):S1. https://doi.org/10.1186/1710-1492-7-s1-s1
Xu M, He L (2010) Convergent evidence shows a positive association of interleukin-1 gene complex locus with susceptibility to schizophrenia in the Caucasian population. Schizophr Res 120:131–142. https://doi.org/10.1016/j.schres.2010.02.1031
Zeni-Graiff M et al (2016) Peripheral immuno-inflammatory abnormalities in ultra-high risk of developing psychosis. Schizophr Res 176:191–195. https://doi.org/10.1016/j.schres.2016.06.031
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Notter, T. (2018). Immunological Processes in Schizophrenia Pathology: Potential Biomarkers?. In: Pratt, J., Hall, J. (eds) Biomarkers in Psychiatry. Current Topics in Behavioral Neurosciences, vol 40. Springer, Cham. https://doi.org/10.1007/7854_2018_43
Download citation
DOI: https://doi.org/10.1007/7854_2018_43
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-99641-7
Online ISBN: 978-3-319-99642-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)